In the BioHarmony Drug Report Database

"Preview" Icon

Retapamulin

Altabax (retapamulin) is a small molecule pharmaceutical. Retapamulin was first approved as Altabax on 2007-04-12. It is used to treat bacterial infections and impetigo in the USA. Altabax’s patents are valid until 2027-02-14 (FDA).

 

Trade Name

 

Altabax
 

Common Name

 

retapamulin
 

ChEMBL ID

 

CHEMBL1658
 

Indication

 

bacterial infections, impetigo
 

Drug Class

 

Antibacterials, pleuromulin derivatives

Image (chem structure or protein)

Retapamulin structure rendering